John Goldberg
Chief Tech/Sci/R&D Officer bij RAFAEL HOLDINGS, INC.
Vermogen: 344 $ op 31-12-2023
Oorsprong van het eerstegraads netwerk van John Goldberg
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 18 | |
| Public Company | Real Estate Development | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John Goldberg via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Comptroller/Controller/Auditor | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IDT CORPORATION | Major Telecommunications | Founder General Counsel | |
Net2Phone, Inc.
 Net2Phone, Inc. Specialty TelecommunicationsCommunications Net2Phone, Inc. engages in the provision of voice-enhanced internet communications services. It offers business messaging, international calling, additional offerings, api integration, analytics, call blocking, call recording, chrome extension, company directory, live chat, mobile app, net2phojne portal, on hold options, ring groups, web calling, and voicemail options. The company was founded in 1996 and is headquartered in Newark, NJ. | Specialty Telecommunications | Chairman Director/Board Member Chief Executive Officer | |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
Straight Path Spectrum, Inc.
 Straight Path Spectrum, Inc. Specialty TelecommunicationsCommunications Straight Path Spectrum, Inc. provides telecommunications and other related services. It provides connections to public networks for telecommunications providers and systems integrators. The company also leases the spectrum to customers who use microwave equipment. Straight Path Spectrum was founded in 2005 and is located in Newark, NJ. | Specialty Telecommunications | Director/Board Member Chief Executive Officer | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| IDW MEDIA HOLDINGS, INC. | Publishing: Books/Magazines | Chairman Corporate Officer/Principal | |
| GENIE ENERGY LTD. | Electric Utilities | Founder Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin | |
| ZEDGE, INC. | Director/Board Member Corporate Secretary Director/Board Member | ||
Photys Therapeutics, Inc.
 Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin | |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree Masters Business Admin | |
IDT Telecom, Inc.
 IDT Telecom, Inc. Specialty TelecommunicationsCommunications IDT Telecom, Inc. provides telecommunications services. The company is headquartered in Newark, NJ. | Specialty Telecommunications | Chairman Director/Board Member | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Auron Therapeutics, Inc.
 Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auron Therapeutics, Inc. operates as a biotechnology company. It aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. The company was founded by Kate Yen, Matt Vander Heiden, Ross Levine, and Eytan Stein and is headquartered in Wellesley, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| The Pennsylvania State University | College/University | Doctorate Degree | |
Charles River Associates (Asia Pacific) Ltd.
 Charles River Associates (Asia Pacific) Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Associates (Asia Pacific) Ltd. provides economic, financial, and management consulting services. It is a subsidiary of CRA International, Inc. The company is headquartered in Brisbane, Australia. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| University of California, Santa Barbara | College/University | Graduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
DEM BioPharma, Inc.
 DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
MTrap, Inc.
 MTrap, Inc. Miscellaneous Commercial ServicesCommercial Services MTrap, Inc. engages in the development of novel therapeutic devices that interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment. The company was founded by Maybelle L. Jordan and is headquartered in Huntington, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Australië | 2 |
Sectoraal
| Health Technology | 25 |
| Commercial Services | 7 |
| Consumer Services | 7 |
| Communications | 5 |
| Finance | 5 |
Operationeel
| Director/Board Member | 159 |
| Corporate Officer/Principal | 57 |
| Independent Dir/Board Member | 49 |
| Chairman | 29 |
| Undergraduate Degree | 28 |
Sterkste connecties
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Howard Jonas | 27 |
| Briggs Morrison | 26 |
| Cameron Wheeler | 20 |
| Alon Lazarus | 18 |
| Barbara Ryan | 18 |
| Scott Canute | 17 |
| Mark McCamish | 15 |
| Douglas Fambrough | 14 |
| Barbara Yanni | 13 |
| Stephen Greenberg | 13 |
| Michael Weiss | 11 |
| John McCabe | 10 |
| David Polinsky | 10 |
| Mary Fenton | 10 |
- Beurs
- Insiders
- John Goldberg
- Bedrijfsconnecties
